20512 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
Short-chain fatty acid hexosamine analogs and their use in tissue engineering applications
#302Glycan-based drugs, therapies and biomarkers
#303Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions
#304COMPOSITIONS OF PARTIALLY DEACETYLATED CHITIN DERIVATIVES
#305TREATMENT OF PETS WITH SIRTUIN ACTIVATORS
#306Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases
#307D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response
#308Acne formulation having stabilized ascorbic acid and other actives
#309Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#310Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
#311C4S proteoglycan specific transporter molecules
#312Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
#313Compounds for use in polycystic kidney disease
#314Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfecton and treatment of oral disease
#315N-ACETYL MANNOSAMMINE AS A THERAPEUTIC AGENT
#316Compositions and formulations of glucosamine for transdermal and transmucosal administration
#317Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
#318Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and joint care components, including type II collagen
#319TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#320Medicinal carbohydrates for treatment of respiratory conditions
#321Composition for preventing or alleviating atopic dermatitis comprising immunosuppressant and transglutaminase 2 inhibitor
#322Composition for reduced scar formation of wounds
#323COMPOUNDS REDUCING THE PRODUCTION OF SORBITOL IN THE EYE AND METHODS OF USING THE SAME
#324AGENT FOR APPLYING TO MUCOSA AND METHOD FOR THE PRODUCTION THEREOF
#325Prion protein ligands as therapeutic agents for neurodegenerative disorders
#326Agent for ameliorating brain hypofunction
#327Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
#328Sialic acid derivatives
#329COMPOSITION AND METHOD FOR PROMOTING JOINT AND BONE HEALTH
#330Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
#331DIETARY SUPPLEMENTS FOR PROMOTION OF GROWTH, REPAIR, AND MAINTENANCE OF BONE AND JOINTS
#332Composition for the treatment of inflammatory and immune disorders
#333MIXTURE FOR THE INHIBITION OF MELANIN BIOSYNTHESIS
#334Compositions and methods for reducing or preventing metastasis
#335Sugar compositions for treating hemophilia A and/or von Willebrand disease
#336Compositions and methods for joint health
#337Combination of an oxidant and a photoactivator for the healing of wounds
#338High concentration alpha-glucosidase compositions for the treatment of Pompe disease
#339CARRIER ENHANCING ABSORPTION OF MEDICATION
#340Composition and method for treating connective tissue damage
#341Reduction of gastrointestinal tract colonisation by campylobacter
#342NEW PHARMACEUTICAL COMPOSITIONS OF FLURBIPROFEN AND GLUCOSAMIN
#343Sialic acid dimers
#344BILAYER TABLET FORMULATIONS OF FLURBIPROFEN AND GLUCOSAMIN
#345PHARMACEUTICAL FORMULATIONS OF FLURBIPROFEN AND GLUCOSAMIN
#346METHOD OF PRODUCING COLLAGEN FROM HYDROLYZED EGG MEMBRANE
#347Methods for inducing orexin neurons and agent for treating narcolepsy or eating disorder
#348COMPOSITIONS AND METHODS FOR TREATING JOINTS
#349Chlorophyll c containing degranulation suppressor
#350SIALIC ACID PRODUCING BACTERIA
#351Persimmon leaf-derived polysaccharide fraction having immune function-enhancing activity and method producing the same
#352Methods and compositions for preventing and treating a disease related to glycan dysregulation
#353Combination of an oxidant and a photoactivator for the healing of wounds
#354Method for acne treatment using an oxidative-photoactivated composition
#355Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress
#356Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
#357Method of enhancing lysosomal α-galactosidase A
#358MIXTURE FOR TRANSDERMAL DELIVERY OF LOW AND HIGH MOLECULAR WEIGHT COMPOUNDS
#359Methods for treating metabolic disorders
#360High concentration α-glucosidase compositions for the treatment of Pompe disease
#361HEALTH SUPPLEMENT
#362Antimicrobial compounds and methods of use
#363Marker for determination of sensitivity to anticancer agent
#364Compositions and methods for localized drug delivery through mammary papillae
#365Substrate reduction therapy
#366X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of CNS inflammation and inflammation associated conditions
#367MULTIPLE FOLATE FORMULATION AND USE THEREOF
#368METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#369Pharmaceutical agents containing carbohydrate moieties and methods of their preparation and use
#370Method for increasing the activity of lysosomal enzymes
#371Pharmaceutical composition, methods for treating and uses thereof
#372Compositions and formulations of glucosamine for transdermal and transmucosal administration
#373Cream composition enhancing skin absorption of glucosamine
#374Substance for preventing and improving arthritis
#375COMPOSITION AND METHOD FOR PROMOTING JOINT AND BONE HEALTH
#376COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS
#377Injectable amino-acid composition
#378COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES
#379TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#380Chemosensory Receptor Ligand-Based Therapies
#381PAIN RELIEVER COMPOSITION
#382Sustained-release pharmaceutical composition
#383IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NUEROLOGIC DISORDERS
#384Compositions of small molecule therapeutics
#385COMPOSITIONS CONTAINING OMEGA-3 OIL AND USES THEREOF
#386-acetyl mannosamine as a therapeutic agent
#387METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE
#388Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
#389X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF CNS INFLAMMATION AND INFLAMMATION ASSOCIATED CONDITIONS
#390Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#391Contraceptive methods and compositions
#392Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#393Method for preventing cancer metastasis
#394ANTI-INFLAMMATORY COMPOSITIONS FOR TREATING BRAIN INFLAMMATION
#395Cosmetic and pharmaceutical composition comprising N-acetylglucosamine-6-phosphate
#396Food composition comprising glucosamine
#397Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases
#398METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#399ACUTE COGNITIVE AND MOOD EFFECTS OF PLANT POLYSACCHARIDES IN ADULT HUMAN SUBJECTS
#400MONOSACCHARIDE-BASED COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE AND INFLAMMATORY DERMATOLOGICAL DISEASES
#401Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
#402TREATMENT COMPOSITION AND METHOD
#403NATURAL PRODUCT INHIBITORS OF 3DG
#404Nutritional supplement to improve supplementary target protein fraction (TPF) delivery, intracellular absorption and utilization
#405COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#406Quality of life of hepatitis C patients with a formulation for administration to the oral mucosa including freeze dried lysate of selected or species and N-acetyl D-glucosamine
#407Artemisinin derivatives with natural amino acids, peptides, and amino sugars for skin imperfections and infection in mammals
#408Polyion complex comprising PHD2 expression inhibiting substance
#409Compositions and methods for treating joints
#410Medicinal carbohydrates for treatment of respiratory conditions
#411Agent for preventing and treating pityriasis versicolor
#412Composition for treatment of tuberculosis
#413Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
#414METHOD FOR PREPARING A MEDICAL SOLUTION FOR THE MANUFACTURE OF A MEDICAMENT FOR PERITONEAL DIALYSIS
#415Food composition comprising glucosamine
#416COMPOSITIONS AND METHODS FOR DETECTING, TREATING, OR PREVENTING REDUCTIVE STRESS
#417ANTI-VIRAL AZIDE-CONTAINING COMPOUNDS
#418Anti-Viral Azide Containing Compounds
#419METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#420Methods of Treatment
#421CAJANUS EXTRACTS AND GLUCOSAMINE FOR INFLAMMATORY DISORDERS
#422Compositions And Beverages Comprising Nutrients, Vitamins, Sugars, Cysteine, And/Or Sugar-Cysteine Products
#423Oral dosage form
#424Therapeutic Liposomes and Methods For Producing and Using the Same
#425Method of fortifying a foodstuff with sialic acid producing bacteria
#426Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including and N-acetyl D-glucosamine
#427Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use
#428PREGNANE GLYCOSIDE COMPOSITIONS AND CARALLUMA EXTRACT PRODUCTS AND USES THEREOF
#429Combination of an oxidant and a photoactivator for the healing of wounds
#430Synthesis of high molecular weight iron-saccharidic complexes
#431Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
#432SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DRIVATIVES THEREOF, UNDENATURED TYPE II COLLAGEN AND, OPTIONALLY, GLUCOSAMINE SULFATE
#433Agent for ameliorating brain hypofunction
#434STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND METHODS OF ANALYZING THEM
#435COMPOSITION FOR TREATING AUTOIMMUNE DISORDERS
#436Agent for applying to mucosa and method for the production thereof
#437Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
#438TRIMETHOXYPHENYL INHIBITORS OF TYROSINE KINASE
#439QUINOLINE INHIBITORS OF TYROSINE KINASE
#440Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#441Compositions comprising sugar-cysteine products
#442Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function
#443Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
#444High Affinity Ligands Bind to Clostridium Difficile Toxin A
#445Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections
#446Nutritional supplement to improve supplementary target protein fraction (TPF) delivery, intracellular absorption and utilization
#447Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
#448Preparations with rosehip extracts, and method of producing rosehip extracts
#449Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#450Treatment of Inflammatory Conditions
#451Glycan-based drugs, therapies and biomarkers
#452Artemisinin derivatives with natural amino acids, peptides, and amino sugars for the treatment of infection and topical condition in mammals
#453Method for increasing the activity of lysosomal enzymes
#454Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
#455Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
#456PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#457Anti-inflammatory compositions for treating brain inflammation
#458Methods for alleviating deleterious effects of 3-deoxyglucosone
#459Compositions and methods for timed release of water-soluble nutritional supplements
#460Method and pharmaceutical to treat spinal discs
#461Nanoparticles for protein drug delivery
#462GLMS RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH GLMS RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH GLMS RIBOSWITCHES
#463Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
#464Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors
#465Method to stabilize a dietary supplement to facilitate joint health in humans
#466ORAL DOSAGE FORM
#467INDAZOLE INHIBITORS OF TYROSINE KINASE
#468Composition for the treatment of osteoarthritis
#469Methods of Treating Skin
#470A COMPOSITION FOR CICATRISATION PROCESSES IN THE TREATMENT OF HYPERTROPHIC SCARS AND FOR IMPROVING THE BIOMECHANICAL PROPERTIES OF THE CUTIS
#471N-acetyl mannosamine as a therapeutic agent
#472Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function
#473PARENTERAL ADMINISTRATION OF A GLUCOSAMINE
#474LIQUID OR PASTE COMPOSITIONS INTENDED TO PROVIDE ELEMENTS ESSENTIAL FOR THE SYNTHESIS AND FORMATION OF PROTEOGLYCANS, IN PARTICULAR, FOR THE TREATMENT OF CARTILAGE DEGRADATION
#475Substrate reduction therapy
#476Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
#477Systems, devices, and methods for making or administering frozen particles
#478Systems, devices, and methods for making or administering frozen particles
#479GLUCOSAMINE AS A FOOD AND BEVERAGE ADDITIVE
#480COMPOSITIONS OF AN ANTICONVULSANT AND MIRTAZAPINE TO PREVENT WEIGHT GAIN
#481SYNTHETIC NUTRITIONAL FORMULATIONS
#482Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
#483Systems, devices, and methods for making or administering frozen particles
#484METHOD OF INCREASING CELLULAR FUNCTION AND HEALTH OF GLUTATHIONE DEFICIENT ANIMALS
#485COMPOSITIONS FOR IMPROVING CELLULAR UPTAKE OF A CHEMOTHERAPEUTIC AGENT IN A CELL EXHIBITING MUCIN DEREGULATION
#486Systems, devices, and methods for making or administering frozen particles
#487Systems, devices and methods for making or administering frozen particles
#488Use of α-glucosidase inhibitors to treat alphavirus infections
#489PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II
#490Method of enhancing lysosomal α-galactosidase A
#491USE OF GLUCOSAMINE AS A MENTAL AND PHYSICAL STRESS RECOVERY ENHANCER AND A PERFORMANCE ENHANCER
#492External preparation composition
#493NATURAL PRODUCT INHIBITORS OF 3DG
#494Compositions for the treatment of chronic degenerative inflammatory conditions
#495EPITOPE REDUCTION THERAPY
#496Meloxicam and glucosamine formulation and uses thereof
#497Cartilage regeneration-promoting agent
#498Use of zwitterionic polysaccharides for the specific modulation of immune processes
#499Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
#500Compositions of partially deacetylated chitin derivatives
#501Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
#502COMPOSITIONS COMPRISING EPOTHILONES AND THEIR USE FOR THE TREATMENT OF CARCINOID SYNDROME
#503HEALTH-RELATED LIQUID COMPOSITIONS
#504Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
#505Compositions for the treatment of exercise induced asthma
#506Compositions of carbohydrates as dietary supplements
#507GERD carbohydrate compositions
#508Drug Delivery System Comprising Microparticles and Gelation System
#509Biocompatible hydrogel compositions
#510COMPOSITIONS COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF
#511Layered drug delivery polymer monofilament fibers
#512AGENT FOR ENHANCHING THE PRODUCTION OF COLLAGEN AND IT'S USE
#513Methods and compositions for preventing and treating a disease related to glycan dysregulation
#514PAIN RELIEF AND SOOTHING CREAM AND METHOD FOR MAKING SAME
#515ACETAMINOPHEN FORMULATION FOR JOINT PAIN RELIEF
#516Natural Anti-Inflammatory Agents for Reducing Pain
#517Method of treatment of skin with external preparation composition
#518AGENT FOR THERAPY OR TREATMENT OF WOUND
#519Method of Improving Treatments in Rheumatic and Arthritic Diseases
#520Compositions For Preventing Or Treating Arthritis Comprising Lactic Acid Bacteria and Collangen As Active Ingredients
#521COMPOSITIONS OF AN ANTICONVULSANT AND AN ANTIPSYCHOTIC DRUG AND METHODS OF USING THE SAME FOR AFFECTING WEIGHT LOSS
#522Inhibitors of polysialic acid de-N-acetylase and methods for using the same
#523Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
#524Carbonyl-substituted titanocenes
#525Compositions of Plant Carbohydrates as Dietary Supplements
#526Animal chew toy containing solid food
#527Health Food and Pharmaceutical Composition for Amelioration of Disease Induced by Metabolic Disorder in Cartilage
#528Agent for Applying to Mucosa and Method for the Production Thereof
#529Combination of Polychitosamine and Fibrate for the Prevention and Treatment of Hyperlipidemia
#530Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
#531External Skin Composition
#532Biologically Active Compounds with Anti-Angiogenic Properties
#533Co-processing of active pharmaceutical/nutraceutical ingredients
#534Compositions and methods for the treatment of cancer
#535Nanoparticles for protein drug delivery
#536Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1
#537RNA targeting compounds and methods for making and using same
#538Tablets Comprising a High Load of Strontium
#539Sustained release compositions using wax-like materials
#540Production of glucosamine from plant species
#541Nanoparticles for protein drug delivery
#542Production Of Glucosamine From Plant Species
#543Activators of Hexosamine Biosynthesis as Inhibitors of Injury Induced by Ischemia or Hermorrhagic Shock
#544Mixture for Transdermal Delivery of Low and High Molecular Weight Compounds
#545Compositions and methods for the treatment of skin
#546PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH MONO- AND DISACCHARIDE-BASED COMPOUNDS
#547Drugs For Diseases Accompanying Changes In Total Bile Acid Pool Or Lipid Metabolism Disorders And Method Of Screening These Drugs
#548Cartilage regeneration promoting agent
#549Compositions and methods for transdermal joint pain therapy
#550Metallo-desferrioxamine complexes and their use in the treatment of bacterial infections
#551Personal care compositions having kinetin or zeatin
#552Nutraceutical with tart cherries and method of treatment therewith
#553Joint preserving nutritional vitamin, mineral and herbal pet supplement
#554Infant Formulas for Early Brain Development
#555Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including subsp. and N-acetyl D-glucosamine
#556Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes
#557Skin care compositions containing a sugar amine
#558Infant formulas for early brain development
#559Method and nutraceutical composition for mammals
#560Composition and method for treating connective tissue damage
#561Flavour modulating substances
#562Compositions and kits comprising a melatonin component and a chondroprotective component
#563N-Acetylglucosamine Tablet Disintegrating In Oral Cavity And Process For Producing The Same
#564METHODS FOR ALLEVIATING DELETERIOUS EFFECTS OF 3-DEOXYGLUCOSONE
#565Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System
#566Uses of diphenyl/diphenylamine carboxylic acids
#567Halide-free glucosamine-therapeutic drug salt compositions
#568Halide-free glucosamine-acidic drug complexes
#569High affinity ligands bind to clostridium difficile toxin A
#570Method for treating warm-blooded vertebrates with a salt of a halide-free glucosamine base and a therapeutic drug
#571Use of organic glucosamine salts
#572Stabilized pentosan polysulfate (PPS) formulations and methods of analyzing them
#573CO-ADMINISTRATION OF ADENOSINE A1 RECEPTOR ANTAGONISTS AND ANTICONVULSANTS
#574Acetaminophen formulation for joint pain relief
#575Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
#576Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
#577Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#578Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis
#579Combined pharmaceutical composition
#580Treatment of degenerative cartilage conditions in a mammal with Glycosidasc Inhibitors
#581Use of n-acetyl-d-aminogylcosamine in preparation of drugs for modulating microorganisms on mucous membrane
#582Compound antibacterial drugs comprising n-acetyl-d-glucosamine
#583Use of lipid conjugates in cystic fibrosis and applications thereof
#584Use of n-acetryl-d-glucosamine in treating and controlling non-specific inflammations caused by physical or chemical factors
#585Use of n-acetyl-d-aminoglycosamine in treatment of local lesions or systematic symptoms related to autoimmune reactions
#586Anti-inflammatory agent
#587COMPOSITIONS OF PLANT CARBOHYDRATES AS DIETARY SUPPLEMENTS
#588Site-specific aminoglycoside derivatives for use in immunodiagnostic assays
#589Treatment of a condition in a mammal with administration of aminosugar and uses thereof
#590Compositions for protection against superficial vasodilator flush syndrome, and methods of use
#591Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
#592Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
#593Food composition comprising glucosamine
#594Aminosugar and/or glycosaminoglycan composition having therapeutic use
#595High-Potency Sweetener Composition with Calcium and Compositions Sweetened Therewith
#596Fertility and anti-aging supplement for the fertility health of females and males
#597Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
#598METHODS AND COMPOSITIONS FOR TREATING PAIN
#599Treatment of a condition in a mammal with administration of Compounds and Methods of Use
#600Capsules comprising topiramate